Stable fetal hemodynamics measured by Doppler flow after initiation of anti-hypertensive treatment with methyldopa in pregnant women with diabetes

References

• Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med 2002;19:482–9
   PubMed Web of Science ®Google Scholar
• Holmes VA, Young IS, Patterson CC, et al. Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011;34:1683–8
   PubMed Web of Science ®Google Scholar
• Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and recommendations for care. Diabet Care 2008;31:1060–79
   Google Scholar
• National Collaborating Centre for Women's and Children's Health (UK).Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. Nice Clinical guidelines, No 107.London: RCOG Press; August 2010 (revised reprint January 2011)
   Google Scholar
• Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118:1–203
   PubMed Web of Science ®Google Scholar
• Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetes with microalbuminuria or diabetic nephropathy: Effect of intensified antihypertensive treatment? Diabetes Care 2009;32:38–44
   PubMed Web of Science ®Google Scholar
• Damm JA, Asbjörnsdóttir B, Callesen NF, et al. Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes. Diabetes Care 2013;36:3489–94
   PubMed Web of Science ®Google Scholar
• Nielsen LR, Muller C, Damm P, Mathiesen ER. Reduced prevalence of early preterm delivery in women with type 1 diabetes and microalbuminuria: possible effect of early antihypertensive treatment during pregnancy. Diabet Med 2006;23:426–31
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Ringholm L, Feldt-Rasmussen B, et al. Obstetric nephrology: pregnancy in women with diabetic nephropathy—the role of antihypertensive treatment. Clin J Am Soc Nephrol 2012;7:2081–8
   PubMed Web of Science ®Google Scholar
• Roza SJ, Steegers EA, Verburg BO, et al. What is spared by fetal brain-sparing? Fetal circulatory redistribution and behavioral problems in the general population. Am J Epidemiol 2008;168:1145–52
   PubMed Web of Science ®Google Scholar
• Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128–32
   PubMed Web of Science ®Google Scholar
• Parra-Cordero M, Lees C, Missfelder-Lobos H, et al. Fetal arterial and venous Doppler pulsatility index and time averaged velocity ranges. Prenat Diagn 2007;27:1251–7
   PubMed Web of Science ®Google Scholar
• Ebbing C, Rasmussen S, Kiserud T. Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacental pulsatility ratio: longitudinal reference ranges and terms for serial measurements. Ultrasound Obstet Gynecol 2007;30:287–96
   PubMed Web of Science ®Google Scholar
• Nielsen LR, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200–1
   PubMed Web of Science ®Google Scholar
• Marsál K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843–8
   PubMed Web of Science ®Google Scholar
• Folic MM, Jankovic SM, Varjacic MR, Folic MD. Effects of metyldopa and nifedipine on uteroplacental and fetal hemodynamics in gestational hypertension. Hypertens Pregn 2012;31:31–9
   PubMed Web of Science ®Google Scholar
• Rey E. Effects of metyldopa on umbilical and placental artery blood flow velocity waveforms. Obstet Gynecol 1992;80:783–7
   PubMed Web of Science ®Google Scholar
• Montan S, Anandakumar C, Arulkumaran S, et al. Effects of metyldopa on uteroplacental and fetal hemodynamics in pregnancy induced hypertension. Am J Obstet Gynecol 1993;168:152–6
   PubMed Web of Science ®Google Scholar
• Montan S, Anandakumar C, Arulkumaran S, et al. Randomised controlled trial of metyldopa and isradipine in preeclampsia; effects on uteroplacental and fetal hemodynamics. J Perinatol Med 1996;24:177–84
   PubMed Web of Science ®Google Scholar
• Günenc O, Cicek N, Görkemli H, et al. The effect of metyldopa treatment on uterine, umbilical and fetal middle cerebral artery blood flows in preeclamptic patients. Arch Gynecol Obstet 2002;266:141–4
   PubMedGoogle Scholar
• Clausen P, Ekbom P, Damm P, et al. Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J Diabet Complic 2007;21:288–93
   PubMed Web of Science ®Google Scholar